Select Page

We need a new Prozac: The demand for brain drug innovation

We need a new Prozac: The demand for brain drug innovation Aug. 15, 2022 · The Pharma Letter An Expert View from Emer Leahy, chief executive, and Dani Brunner, chief innovation officer, of PsychoGenics, on the challenges involved in tackling mental disorders. One of...

The CNS drug development drum beat is getting louder

The CNS drug development drum beat is getting louder By Brian Buntz | August 1, 2022 [image courtesy of Pixabay] The late 1980s and the 1990s were something of a gold rush for pharmaceutical companies focused on CNS drug development — especially those developing...